Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yuanyong Xu is active.

Publication


Featured researches published by Yuanyong Xu.


Antimicrobial Agents and Chemotherapy | 2012

An Outbreak of Mycoplasma pneumoniae Caused by a Macrolide-Resistant Isolate in a Nursery School in China

Yong Wang; Shaofu Qiu; Guang Yang; Lixue Song; Wenli Su; Yuanyong Xu; Leili Jia; Ligui Wang; Rongzhang Hao; Chuanfu Zhang; Jingmei Liu; Xiuping Fu; Jinrong He; Jingshan Zhang; Zhenjun Li; Hongbin Song

ABSTRACT Eighteen out of 45 children were reported to have a respiratory illness during an outbreak at a temporary dormitory in a nursery school in China in 2011. To study the outbreak and to determine the risk factors for infection, an epidemiological investigation was performed. A standardized questionnaire was completed for a total of 45 children with the help of their guardians and parents. In addition, acute- and convalescent-phase serum samples and throat swabs from the children were taken for laboratory diagnosis. The diagnosis of a Mycoplasma-like illness was based on the following clinical criteria. The criteria were onset of illness after 31 May 2011, characterized by a cough, fever(>37.5°C), or at least 3 of the following symptoms: fever, sore throat, cough or expectoration, and runny or stuffy nose. PCR-restriction fragment length polymorphism (PCR-RFLP), determination of MICs, and sequencing were performed to determine the genotype, antibiotic resistance, and sequence polymorphisms of the isolated strains, respectively. The paired sera revealed that 15 patients were infected with Mycoplasma pneumoniae. Epidemiology confirmed that this was a point source outbreak, characterized by a short incubation period, a high secondary attack rate, and a long period of hospitalization. PCR-RFLP analysis revealed that the 12 isolated strains of M. pneumoniae shared the same subtype P1 gene, and 23S rRNA sequence analysis showed that these strains harbored two macrolide-resistant gene-related point mutations at position 2063 and 2617. In this outbreak, the major risk factor was the distance between the bed of the first patient and the beds of close contacts (beds less than three meters apart). The strains isolated in this study were found to harbor two point mutations conferring macrolide resistance, indicating the importance of pathogen and drug resistance surveillance systems.


Virology Journal | 2010

A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement.

Leili Jia; Yuanyong Xu; Chuanfu Zhang; Yong Wang; Huihui Chong; Shaofu Qiu; Ligui Wang; Yanwei Zhong; Weijing Liu; Yansong Sun; Fei Qiao; Stephen Tomlinson; Hongbin Song; Yusen Zhou; Yuxian He

BackgroundThe complement system is not only a key component of innate immunity but also provides a first line of defense against invading pathogens, especially for viral pathogens. Human immunodeficiency virus (HIV), however, possesses several mechanisms to evade complement-mediated lysis (CoML) and exploit the complement system to enhance viral infectivity. Responsible for this intrinsic resistance against complement-mediated virolysis are complement regulatory membrane proteins derived from the host cell that inherently downregulates complement activation at several stages of the cascade. In addition, HIV is protected from complement-mediated lysis by binding soluble factor H (fH) through the viral envelope proteins, gp120 and gp41. Whereas inhibition of complement activity is the desired outcome in the vast majority of therapeutic approaches, there is a broader potential for complement-mediated inhibition of HIV by complement local stimulation.Presentation of the hypothesisOur previous studies have proven that the complement-mediated antibody-dependent enhancement of HIV infection is mediated by the association of complement receptor type 2 bound to the C3 fragment and deposited on the surface of HIV virions. Thus, we hypothesize that another new activator of complement, consisting of two dsFv (against gp120 and against C3d respectively) linked to a complement-activating human IgG1 Fc domain ((anti-gp120 × anti-C3d)-Fc), can not only target and amplify complement activation on HIV virions for enhancing the efficiency of HIV lysis, but also reduce the infectivity of HIV through blocking the gp120 and C3d on the surface of HIV.Testing the hypothesisOur hypothesis was tested using cell-free HIV-1 virions cultivated in vitro and assessment of virus opsonization was performed by incubating appropriate dilutions of virus with medium containing normal human serum and purified (anti-gp120 × anti-C3d)-Fc proteins. As a control group, viruses were incubated with normal human serum under the same conditions. Virus neutralization assays were used to estimate the degree of (anti-gp120 × anti-C3d)-Fc lysis of HIV compared to untreated virus.Implications of the hypothesisThe targeted complement activator, (anti-gp120 × anti-C3d)-Fc, can be used as a novel approach to HIV therapy by abrogating the complement-enhanced HIV infection of cells.


BMJ | 2013

The next step in controlling HBV in China

Yuanyong Xu; Huihui Liu; Yong Wang; Rongzhang Hao; Zhenjun Li; Hongbin Song

Focus on preventing perinatal transmission of the virus


Clinical Infectious Diseases | 2010

Multilocus Outbreak of Foodborne Botulism Linked to Contaminated Sausage in Hebei Province, China

Zhang S; Yong Wang; Shaofu Qiu; Yonghui Dong; Yuanyong Xu; Deyong Jiang; Xiuping Fu; Jingshan Zhang; Jinrong He; Leili Jia; Ligui Wang; Chuanfu Zhang; Yansong Sun; Hongbin Song

In 2007, an outbreak of foodborne botulism occurred in Hebei province, China. An epidemiological investigation and laboratory detection studies showed that sausage contaminated by type A Clostridium botulinum caused this outbreak of food poisoning. Its clinical and epidemiological features were different from previous reports of food poisoning.


Virology Journal | 2009

A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement

Yuanyong Xu; Chuanfu Zhang; Leili Jia; Cuirong Wen; Huihui Liu; Yong Wang; Yansong Sun; Liuyu Huang; Yusen Zhou; Hongbin Song

BackgroundThe complement system is one of the most potent weapons of innate immunity. It is not only a mechanism for direct protection against invading pathogens but it also interacts with the adaptive immunity to optimize the pathogen-specific humoral and cellular defense cascades in the body. Complement-mediated lysis of HIV is inefficient but the presence of HIV particles results in complement activation by the generation of many C3-fragments, such as C3dg and C3d. It has been demonstrated that activation of complement can enhance HIV infection through the binding of special complement receptor type 2 expression on the surface of mature B cells and follicular dendritic cells.Presentation of the hypothesisPrevious studies have proven that the complement-mediated antibody-dependent enhancement of HIV infection is mediated by the association of complement receptor type 2 bound to the C3 fragment and deposited on the surface of HIV virions. Thus, we hypothesize that a new activator of complement, consisting of a target domain (C3-binding region of complement receptor type 2) linked to a complement-activating human IgG1 Fc domain (CR2-Fc), can target and amplify complement deposition on HIV virions and enhance the efficiency of HIV lysis.Testing the hypothesisOur hypothesis was tested using cell-free HIV-1 virions cultivated in vitro and assessment of virus opsonization was performed by incubating appropriate dilutions of virus with medium containing normal human serum and purified CR2-Fc proteins. As a control group, viruses were incubated with normal human serum under the same conditions. Virus neutralization assays were used to estimate the degree of CR2-Fc-enhanced lysis of HIV compared to untreated virus.Implications of the hypothesisThe targeted complement activator, CR2-Fc, can be used as a novel approach to HIV therapy by abrogating the complement-enhanced HIV infection of cells.


Scientific Reports | 2015

Transmission Characteristics of Different Students during a School Outbreak of (H1N1) pdm09 Influenza in China, 2009

Ligui Wang; Chenyi Chu; Guang Yang; Rongzhang Hao; Zhenjun Li; Zhidong Cao; Shaofu Qiu; Peng Li; Zhihao Wu; Zhengquan Yuan; Yuanyong Xu; Dajun Zeng; Yong Wang; Hongbin Song

Many outbreaks of A(H1N1)pdm09 influenza have occurred in schools with a high population density. Containment of school outbreaks is predicted to help mitigate pandemic influenza. Understanding disease transmission characteristics within the school setting is critical to implementing effective control measures. Based on a school outbreak survey, we found almost all (93.7%) disease transmission occurred within a single grade, only 6.3% crossed grades. Transmissions originating from freshmen exhibited a star-shaped network; other grades exhibited branch- or line-shaped networks, indicating freshmen have higher activity and are more likely to cause infection. R0 for freshmen, calculated as 2.04, estimated as 2.76, was greater than for other grades (P < 0.01). Without intervention, the estimated number of cases was much greater when the outbreak was initiated by freshmen than by other grades. Furthermore, the estimated number of cases required to be under quarantine and isolation for freshmen was less than that of equivalent other grades. So we concluded that different grades have different transmission mode. Freshmen were the main facilitators of the spread of A(H1N1)pdm09 influenza during this school outbreak, so control measures (e.g. close contact isolation) priority used for freshmen would likely have effectively reduced spread of influenza in school settings.


Virology Journal | 2010

A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitior

Chuanfu Zhang; Yuanyong Xu; Leili Jia; Yutao Yang; Yong Wang; Yansong Sun; Liuyu Huang; Fei Qiao; Stephen Tomlinson; Xuelin Liu; Yusen Zhou; Hongbin Song


International Journal of Biological Sciences | 2008

Screening of Human Antibody Fab Fragment against HBsAg and the Construction of its dsFv Form

Leili Jia; Jiyun Yu; Hongbin Song; Xuelin Liu; Weina Ma; Yuanyong Xu; Chuanfu Zhang; Shicun Dong; Qiao Li


International Journal of Biological Sciences | 2009

HCV Antibody Response and Genotype Distribution in Different Areas and Races of China

Leili Jia; Jiyun Yu; Jinliang Yang; Hongbin Song; Xuelin Liu; Yong Wang; Yuanyong Xu; Chuanfu Zhang; Yanwei Zhong; Qiao Li


Clinical Infectious Diseases | 2015

Epidemiologic Features of AIDS in China, 2004–2013

Yuanyong Xu; Guang Yang; Huihui Liu; Xinxin Li; Lixue Song; Yanan Li; Yong Wang; Shenlong Li; Hongbin Song

Collaboration


Dive into the Yuanyong Xu's collaboration.

Top Co-Authors

Avatar

Hongbin Song

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Yong Wang

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Chuanfu Zhang

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Leili Jia

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Yansong Sun

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Ligui Wang

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Yusen Zhou

Central South University

View shared research outputs
Top Co-Authors

Avatar

Liuyu Huang

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Shaofu Qiu

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Xuelin Liu

Academy of Military Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge